In this regard, Jensen et al. (2011) show that FOXO3a is activated in vivo in hypoxic tumor tissue and that elevated ROS following FOXO3a silencing sensitizes cells to hypoxia-induced cell death. Here, FOXO3 is linked to neoplasm.